Global Therapeutic Drug Monitoring Consumables Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Therapeutic Drug Monitoring Consumables market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic Drug Monitoring Consumables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Therapeutic Drug Monitoring Consumables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Therapeutic Drug Monitoring Consumables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Therapeutic Drug Monitoring Consumables is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Therapeutic Drug Monitoring Consumables include Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Sekisui Medical Co., Ltd, Exagen Inc, Danaher Corporation, Bio-Rad Laboratories and bioMérieux SA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Therapeutic Drug Monitoring Consumables, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Therapeutic Drug Monitoring Consumables, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Drug Monitoring Consumables, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Drug Monitoring Consumables sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Therapeutic Drug Monitoring Consumables market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Therapeutic Drug Monitoring Consumables sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Drug Monitoring Consumables Segment by Company

Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Sekisui Medical Co., Ltd
Exagen Inc
Danaher Corporation
Bio-Rad Laboratories
bioMérieux SA
Alere, Inc.
Therapeutic Drug Monitoring Consumables Segment by Type

Immunoassay Consumables
Chromatography & Mass Spectrometry Consumables
Therapeutic Drug Monitoring Consumables Segment by Application

Commercial & Private Laboratories
Research and Academic Institutes
Hospital Laboratories
Therapeutic Drug Monitoring Consumables Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring Consumables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring Consumables and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring Consumables.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Therapeutic Drug Monitoring Consumables market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring Consumables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Drug Monitoring Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Therapeutic Drug Monitoring Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Therapeutic Drug Monitoring Consumables Market Size, 2020 VS 2024 VS 2031
1.3 Global Therapeutic Drug Monitoring Consumables Market Size Estimates and Forecasts (2020-2031)
1.4 Global Therapeutic Drug Monitoring Consumables Sales Estimates and Forecasts (2020-2031)
1.5 Global Therapeutic Drug Monitoring Consumables Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Therapeutic Drug Monitoring Consumables Market Dynamics
2.1 Therapeutic Drug Monitoring Consumables Industry Trends
2.2 Therapeutic Drug Monitoring Consumables Industry Drivers
2.3 Therapeutic Drug Monitoring Consumables Industry Opportunities and Challenges
2.4 Therapeutic Drug Monitoring Consumables Industry Restraints
3 Therapeutic Drug Monitoring Consumables Market by Manufacturers
3.1 Global Therapeutic Drug Monitoring Consumables Revenue by Manufacturers (2020-2025)
3.2 Global Therapeutic Drug Monitoring Consumables Sales by Manufacturers (2020-2025)
3.3 Global Therapeutic Drug Monitoring Consumables Average Sales Price by Manufacturers (2020-2025)
3.4 Global Therapeutic Drug Monitoring Consumables Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Therapeutic Drug Monitoring Consumables Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Therapeutic Drug Monitoring Consumables Manufacturers, Product Type & Application
3.7 Global Therapeutic Drug Monitoring Consumables Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Therapeutic Drug Monitoring Consumables Market CR5 and HHI
3.8.2 Global Top 5 and 10 Therapeutic Drug Monitoring Consumables Players Market Share by Revenue in 2024
3.8.3 2024 Therapeutic Drug Monitoring Consumables Tier 1, Tier 2, and Tier 3
4 Therapeutic Drug Monitoring Consumables Market by Type
4.1 Therapeutic Drug Monitoring Consumables Type Introduction
4.1.1 Immunoassay Consumables
4.1.2 Chromatography & Mass Spectrometry Consumables
4.2 Global Therapeutic Drug Monitoring Consumables Sales by Type
4.2.1 Global Therapeutic Drug Monitoring Consumables Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Therapeutic Drug Monitoring Consumables Sales by Type (2020-2031)
4.2.3 Global Therapeutic Drug Monitoring Consumables Sales Market Share by Type (2020-2031)
4.3 Global Therapeutic Drug Monitoring Consumables Revenue by Type
4.3.1 Global Therapeutic Drug Monitoring Consumables Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Therapeutic Drug Monitoring Consumables Revenue by Type (2020-2031)
4.3.3 Global Therapeutic Drug Monitoring Consumables Revenue Market Share by Type (2020-2031)
5 Therapeutic Drug Monitoring Consumables Market by Application
5.1 Therapeutic Drug Monitoring Consumables Application Introduction
5.1.1 Commercial & Private Laboratories
5.1.2 Research and Academic Institutes
5.1.3 Hospital Laboratories
5.2 Global Therapeutic Drug Monitoring Consumables Sales by Application
5.2.1 Global Therapeutic Drug Monitoring Consumables Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Therapeutic Drug Monitoring Consumables Sales by Application (2020-2031)
5.2.3 Global Therapeutic Drug Monitoring Consumables Sales Market Share by Application (2020-2031)
5.3 Global Therapeutic Drug Monitoring Consumables Revenue by Application
5.3.1 Global Therapeutic Drug Monitoring Consumables Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Therapeutic Drug Monitoring Consumables Revenue by Application (2020-2031)
5.3.3 Global Therapeutic Drug Monitoring Consumables Revenue Market Share by Application (2020-2031)
6 Global Therapeutic Drug Monitoring Consumables Sales by Region
6.1 Global Therapeutic Drug Monitoring Consumables Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Therapeutic Drug Monitoring Consumables Sales by Region (2020-2031)
6.2.1 Global Therapeutic Drug Monitoring Consumables Sales by Region (2020-2025)
6.2.2 Global Therapeutic Drug Monitoring Consumables Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Therapeutic Drug Monitoring Consumables Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Therapeutic Drug Monitoring Consumables Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Therapeutic Drug Monitoring Consumables Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Therapeutic Drug Monitoring Consumables Revenue by Region
7.1 Global Therapeutic Drug Monitoring Consumables Revenue by Region
7.1.1 Global Therapeutic Drug Monitoring Consumables Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Therapeutic Drug Monitoring Consumables Revenue by Region (2020-2025)
7.1.3 Global Therapeutic Drug Monitoring Consumables Revenue by Region (2026-2031)
7.1.4 Global Therapeutic Drug Monitoring Consumables Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Therapeutic Drug Monitoring Consumables Revenue (2020-2031)
7.2.2 North America Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Therapeutic Drug Monitoring Consumables Revenue (2020-2031)
7.3.2 Europe Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Therapeutic Drug Monitoring Consumables Revenue (2020-2031)
7.4.2 Asia-Pacific Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Therapeutic Drug Monitoring Consumables Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Comapny Information
8.1.2 Abbott Laboratories Business Overview
8.1.3 Abbott Laboratories Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Abbott Laboratories Therapeutic Drug Monitoring Consumables Product Portfolio
8.1.5 Abbott Laboratories Recent Developments
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Comapny Information
8.2.2 Thermo Fisher Scientific Business Overview
8.2.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Consumables Product Portfolio
8.2.5 Thermo Fisher Scientific Recent Developments
8.3 F. Hoffmann-La Roche Ltd
8.3.1 F. Hoffmann-La Roche Ltd Comapny Information
8.3.2 F. Hoffmann-La Roche Ltd Business Overview
8.3.3 F. Hoffmann-La Roche Ltd Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 F. Hoffmann-La Roche Ltd Therapeutic Drug Monitoring Consumables Product Portfolio
8.3.5 F. Hoffmann-La Roche Ltd Recent Developments
8.4 Siemens Healthineers AG
8.4.1 Siemens Healthineers AG Comapny Information
8.4.2 Siemens Healthineers AG Business Overview
8.4.3 Siemens Healthineers AG Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Siemens Healthineers AG Therapeutic Drug Monitoring Consumables Product Portfolio
8.4.5 Siemens Healthineers AG Recent Developments
8.5 Sekisui Medical Co., Ltd
8.5.1 Sekisui Medical Co., Ltd Comapny Information
8.5.2 Sekisui Medical Co., Ltd Business Overview
8.5.3 Sekisui Medical Co., Ltd Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sekisui Medical Co., Ltd Therapeutic Drug Monitoring Consumables Product Portfolio
8.5.5 Sekisui Medical Co., Ltd Recent Developments
8.6 Exagen Inc
8.6.1 Exagen Inc Comapny Information
8.6.2 Exagen Inc Business Overview
8.6.3 Exagen Inc Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Exagen Inc Therapeutic Drug Monitoring Consumables Product Portfolio
8.6.5 Exagen Inc Recent Developments
8.7 Danaher Corporation
8.7.1 Danaher Corporation Comapny Information
8.7.2 Danaher Corporation Business Overview
8.7.3 Danaher Corporation Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Danaher Corporation Therapeutic Drug Monitoring Consumables Product Portfolio
8.7.5 Danaher Corporation Recent Developments
8.8 Bio-Rad Laboratories
8.8.1 Bio-Rad Laboratories Comapny Information
8.8.2 Bio-Rad Laboratories Business Overview
8.8.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Consumables Product Portfolio
8.8.5 Bio-Rad Laboratories Recent Developments
8.9 bioMérieux SA
8.9.1 bioMérieux SA Comapny Information
8.9.2 bioMérieux SA Business Overview
8.9.3 bioMérieux SA Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 bioMérieux SA Therapeutic Drug Monitoring Consumables Product Portfolio
8.9.5 bioMérieux SA Recent Developments
8.10 Alere, Inc.
8.10.1 Alere, Inc. Comapny Information
8.10.2 Alere, Inc. Business Overview
8.10.3 Alere, Inc. Therapeutic Drug Monitoring Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Alere, Inc. Therapeutic Drug Monitoring Consumables Product Portfolio
8.10.5 Alere, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Therapeutic Drug Monitoring Consumables Value Chain Analysis
9.1.1 Therapeutic Drug Monitoring Consumables Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Therapeutic Drug Monitoring Consumables Production Mode & Process
9.2 Therapeutic Drug Monitoring Consumables Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Therapeutic Drug Monitoring Consumables Distributors
9.2.3 Therapeutic Drug Monitoring Consumables Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings